
Potential Breakthrough Drug Could Prevent Alzheimer's Before Memory Loss
Scientists at Northwestern University discovered a novel compound, NU-9, that can target a previously unknown subtype of brain protein associated with early Alzheimer's disease in mice, potentially allowing for preventative treatment similar to managing high cholesterol. The compound reduces toxic proteins and inflammation, paving the way for future research on its effectiveness in later stages and its potential to control the disease before symptoms appear.







